Finance

Lists
EVONILE:NSE
Novartis India Ltd
₹1,717.90
+0.01%
(+0.20) 1D
Nov 3, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for EVONILE...
Open
₹1,739.00
High
₹1,744.10
Low
₹1,672.50
Mkt. cap
48.73B
Avg. vol.
44.55K
Volume
27.27K
P/E ratio
43.37
52-wk high
₹2,588.80
52-wk low
₹950.00
EPS
₹39.61
No. of employees
57
Open
₹1,739.00
High
₹1,744.10
Low
₹1,672.50
Mkt. cap
48.73B
Avg. vol.
44.55K
Volume
27.27K
P/E ratio
43.37
52-wk high
₹2,588.80
52-wk low
₹950.00
EPS
₹39.61
No. of employees
57
News stories
From web sources and news partners
About Novartis India Ltd
CEO-
Employees57
FoundedDec 13, 1947
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Last report
Nov 4, 2026
Fiscal period
Q2 2027
- / -
Revenue / Est. (INR)
560.50M / -
Fiscal Q2 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
859.00M
905.50M
1.04B
560.50M
Cost of goods sold
489.00M
521.80M
556.70M
470.90M
Cost of revenue
489.00M
521.80M
556.70M
470.90M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
61.40M
61.00M
47.20M
143.50M
Operating expense
151.20M
159.10M
136.50M
446.70M
Total operating expenses
640.20M
680.90M
693.20M
917.60M
Operating income
218.80M
224.60M
344.90M
-357.10M
Other non operating income
87.50M
-281.90M
87.40M
77.40M
EBT including unusual items
296.50M
301.40M
431.70M
-1.01B
EBT excluding unusual items
296.50M
301.60M
431.70M
-328.00M
Income tax expense
135.60M
48.90M
109.60M
-235.20M
Effective tax rate
45.73%
16.22%
25.39%
23.27%
Other operating expenses
85.30M
94.60M
84.80M
264.30M
Net income
160.90M
252.50M
322.10M
-775.40M
Net profit margin
18.73%
27.89%
31.03%
-138.34%
Earnings per share
-
-
-
-
Interest and investment income
-
382.20M
-
-
Interest expense
-9.80M
-700.00K
-600.00K
-48.30M
Net interest expenses
-9.80M
381.50M
-600.00K
-48.30M
Depreciation and amortization charges
4.80M
4.20M
4.20M
38.90M
EBITDA
219.98M
225.70M
349.78M
-335.55M
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps